SPOiLER: towards Safer Prescribing of Legal Opioids from the Emergency Room
剧透:在急诊室更安全地开出合法阿片类药物
基本信息
- 批准号:10364730
- 负责人:
- 金额:$ 18.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-03-01 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:Accident and Emergency departmentAcuteApplications GrantsAttitudeBehaviorBehavioralBeliefBenefits and RisksCharacteristicsChronicClinicalCohort AnalysisDataDatabasesDependenceDevelopmentDrug MonitoringDrug PrescriptionsEducationEmergency Department PhysicianEmergency Department patientEmergency SituationEpidemicEquilibriumEventEvidence based practiceFrequenciesFundingFutureGoalsGrantHarm ReductionHospitalsIndividualInterviewLeadershipLegalMassachusettsMentorsMethodsNational Institute of Drug AbuseNew HampshireOpioidOutpatientsOverdosePainPatient-Focused OutcomesPatientsPhysiciansPlanning TheoryPoliciesPolicy ResearchProbabilityProviderQualitative MethodsQuasi-experimentRegulationResearchResearch PersonnelResearch Project GrantsRetrospective cohortRiskRoleState GovernmentStatutes and LawsStructureSubstance Use DisorderTrainingUnited Statesaddictionadverse outcomebasebehavior changebehavioral outcomecareer developmentclinically relevantevidence baseevidence based guidelinesexperiencehealth care service utilizationimplementation trialindexingnonmedical useopioid epidemicopioid policyopioid therapyopioid useopioid use disorderpeerpillprescription opioidpreventsocial normtheories
项目摘要
PROJECT SUMMARY
The objective of this NIDA K08 career development proposal is to gain experience and training to
become an independent investigator focused on the development of evidence-based practices to prevent and
treat substance use disorders in the emergency department. Opioid use disorders, including overdose and
addiction, have become epidemic in the United States. While research has largely focused on long-term opioid
prescribing in the outpatient setting, emergency department opioid prescribing for acute painful conditions as a
portal for future adverse patient outcomes remains poorly defined.
State governments, including the Commonwealth of Massachusetts, have reacted to the opioid crisis in
part by crafting legislation to broadly limit legal opioid prescriptions. However, opioid medications remain an
important treatment option for some acute painful conditions, and evidence based guidance on appropriate
prescribing is lacking, in part because the factors that impact providers opioid prescribing behaviors and
subsequent patient associated adverse outcomes remains unknown. Understanding the underlying
factors that influence opioid prescribing behaviors and future patient outcomes, including state legislation, peer
behaviors, hospital attitudes, and local culture, is a critical step in developing integrated, evidence-based
recommendations that focus on transforming the culture surrounding safe opioid prescribing practices.
Using the theory of planned behavior as a framework, the goals of this K08 grant application are to
understand opioid prescribing behaviors and adverse patient outcomes through the following aims: First, we
will assess the influence of state legislation, specifically the 2016 Massachusetts (MA) Opioid Law, on the
formation of hospital-based regulations and providers' perceived attitudes towards opioid prescribing through
qualitative interviews with local physician leaders in MA. Second, using comprehensive claims data, we will
evaluate the impact of the 2016 MA Opioid Law on statewide opioid prescribing, using a neighboring state
without opioid legislation as a natural control. Finally, we will examine the association of an initial opioid
prescription on clinically relevant patient outcomes in order to better understand how restricting opioid
prescriptions through legislation may impact emergency department patients presenting with an acute painful
condition.
From our results, we will create evidence-based recommendations to enhance existing opioid
legislation, as well as develop and execute R01 funded comprehensive implementation trials that focus not
only on changing behaviors of individual providers, but also transforming the group culture and social norms
that influence opioid prescribing behaviors.
!
项目概要
NIDA K08 职业发展建议的目标是获得经验和培训
成为一名独立调查员,专注于开发基于证据的实践,以预防和
在急诊科治疗药物滥用障碍。阿片类药物使用障碍,包括过量和
成瘾,在美国已成为一种流行病。虽然研究主要集中在长期阿片类药物
在门诊、急诊室开阿片类药物治疗急性疼痛情况
未来患者不良结果的门户仍然不明确。
包括马萨诸塞州在内的州政府已对阿片类药物危机做出了反应
部分方法是制定立法来广泛限制合法的阿片类药物处方。然而,阿片类药物仍然是一种
一些急性疼痛病症的重要治疗选择,以及适当的循证指导
缺乏处方,部分原因是影响提供者阿片类药物处方行为的因素和
随后与患者相关的不良后果仍然未知。了解底层
影响阿片类药物处方行为和未来患者结果的因素,包括国家立法、同行
行为、医院态度和当地文化,是制定综合的、基于证据的关键一步
重点关注改变阿片类药物安全处方文化的建议。
以计划行为理论为框架,本次 K08 拨款申请的目标是
通过以下目标了解阿片类药物处方行为和不良患者结果:首先,我们
将评估州立法,特别是 2016 年马萨诸塞州 (MA) 阿片类药物法对
通过以下方式形成基于医院的法规和提供者对阿片类药物处方的认知态度:
对马萨诸塞州当地医生领导者的定性访谈。其次,利用综合理赔数据,我们将
使用邻近州评估 2016 年 MA 阿片类药物法对全州阿片类药物处方的影响
没有阿片类药物立法作为自然控制。最后,我们将检查初始阿片类药物的关联
根据临床相关患者结果开具处方,以便更好地了解如何限制阿片类药物
通过立法的处方可能会影响急诊室的急性疼痛患者
健康)状况。
根据我们的结果,我们将提出基于证据的建议,以增强现有的阿片类药物
立法,以及制定和执行 R01 资助的全面实施试验,重点不在于
不仅要改变个体提供者的行为,还要改变群体文化和社会规范
影响阿片类药物处方行为。
!
项目成果
期刊论文数量(9)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
William Edward Soares其他文献
William Edward Soares的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('William Edward Soares', 18)}}的其他基金
SPOiLER: towards Safer Prescribing of Legal Opioids from the Emergency Room
剧透:在急诊室更安全地开出合法阿片类药物
- 批准号:
10116352 - 财政年份:2018
- 资助金额:
$ 18.47万 - 项目类别:
相似国自然基金
Tenascin-X对急性肾损伤血管内皮细胞的保护作用及机制研究
- 批准号:82300764
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
活性脂质Arlm-1介导的自噬流阻滞在儿童T细胞急性淋巴细胞白血病化疗耐药逆转中的作用机制研究
- 批准号:82300182
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
PHF6突变通过相分离调控YTHDC2-m6A-SREBP2信号轴促进急性T淋巴细胞白血病发生发展的机制研究
- 批准号:82370165
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
KIF5B调控隧道纳米管介导的线粒体转运对FLT3-ITD阳性急性髓系白血病的作用机制
- 批准号:82370175
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Actionable categories of avoidable hospital care among adults with cancer
成人癌症患者可避免住院治疗的可行类别
- 批准号:
10714125 - 财政年份:2023
- 资助金额:
$ 18.47万 - 项目类别:
Development of TNX-1300 (Double Mutant Cocaine Esterase) for the Treatment of Life-Threatening Cocaine Intoxication
开发 TNX-1300(双突变可卡因酯酶)用于治疗危及生命的可卡因中毒
- 批准号:
10668212 - 财政年份:2022
- 资助金额:
$ 18.47万 - 项目类别:
Pediatric Respiratory Illness Measurement System (PRIMES) Implementation in Community Hospital Settings
儿科呼吸疾病测量系统 (PRIMES) 在社区医院的实施
- 批准号:
10689215 - 财政年份:2021
- 资助金额:
$ 18.47万 - 项目类别:
Pediatric Respiratory Illness Measurement System (PRIMES) Implementation in Community Hospital Settings
儿科呼吸疾病测量系统 (PRIMES) 在社区医院的实施
- 批准号:
10491041 - 财政年份:2021
- 资助金额:
$ 18.47万 - 项目类别:
SPOiLER: towards Safer Prescribing of Legal Opioids from the Emergency Room
剧透:在急诊室更安全地开出合法阿片类药物
- 批准号:
10116352 - 财政年份:2018
- 资助金额:
$ 18.47万 - 项目类别: